Photo Credit: COURTESY IMAGE
In a potential game changer for the treatment of superbugs, a new class of antibiotics was developed that cured mice infected with bacteria deemed nearly “untreatable” in humans — and resistance to the drug was virtually undetectable.
Developed by a research team of UC Santa Barbara scientists, the study was published(link is external) in the journal eBioMedicine. The drug works by disrupting many bacterial functions simultaneously — which may explain how it killed every pathogen tested and why low-level of bacterial resistance was observed after prolonged drug exposure.
The project was led by professors Michael Mahan, David Low, Chuck Samuel and their research team, Douglas Heithoff, Scott Mahan, Lucien Barnes and Cyril George. Additional contributors include professors Guillermo Bazan (UC Santa Barbara) and Andrei Osterman (Sanford Burnham Prebys Medical Discovery Institute).
The discovery was serendipitous. The U.S. Army had a pressing need to charge cell phones while in the field — essential for soldier survival. Because bacteria are miniature power plants, compounds were designed by Bazan’s group to harness bacterial energy as a “microbial” battery. Later the idea arose to re-purpose these compounds as potential antibiotics.
“When asked to determine if the chemical compounds could serve as antibiotics, we thought they would be highly toxic to human cells similar to bleach,” said Mahan, the project lead. “Most were toxic — but one was not — and it could kill every bacterial pathogen we tested.”
What makes the drug unique is the failure of bacteria to become resistant to it. And bacterial resistance is typically a major barrier to antibiotic development since it limits a drug’s (potential value in the marketplace.
“The key finding was that bacterial resistance to the drug was virtually undetectable,” said lead author Heithoff. “Most drugs fail at this stage of development and never get to clinical practice.”
The antibiotic has a unique mechanism of action. Contrary to most drugs (like penicillin) that target a specific germ function, the new drug targets many functions simultaneously.
“The drug appears to affect the bacterial membrane which, in turn, disrupts multiple bacterial functions,” explained Low, the co-project lead. “This may account for the broad-spectrum antibacterial activity and low level of bacterial resistance.”
“This class of antibiotics has potential as a new versatile therapy for antimicrobial resistant pathogens,” Samuel said.
Additional drug safety and efficacy studies will need to be conducted to fully understand the clinical benefits and risks before the drug can be used in clinical practice.
Original Article: Resistance Is Futile
More from: University of California Santa Barbara | Sanford Burnham Prebys Medical Discovery Institute
The Latest Updates from Bing News
Go deeper with Bing News on:
Superbugs
- 'Just in case' antibiotics widely overused during COVID-19, says UN health agency
Antibiotics saw 'extensive overuse' globally among hospitalised COVID-19 patients during the pandemic without improving clinical outcomes, while also potentially increasing the already serious and ...
- Superbugs could lower your life expectancy by nearly 2 years, report says. What to know about antimicrobial resistance
Public Health Emergency, a group of international political, public health, and biomedical leaders warns of another menace to human life that could also trigger economic loss. Antimicrobial ...
- Artificial Intelligence Help Prevent Superbugs
AI successfully devised highly efficient antibiotic cycling strategies for treating multiple strains of E. coli, effectively thwarting drug resistance.
- Study finds AI can develop treatments to prevent 'superbugs'
Cleveland Clinic researchers developed an artificial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based ...
- Artificial intelligence can develop treatments to prevent 'superbugs'
Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based ...
Go deeper with Bing News on:
New class of antibiotics
- After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
A new Science paper from the Baker lab details a novel method for quickly compiling a large library of macrocycle drug candidates.
- Are Weight Loss Drugs Safe During Pregnancy?
GLP-1 receptor agonists like Ozempic aren't recommended during pregnancy. Here's why and what to do if you discover you're pregnant while taking them.
- FDA approves new antibiotic against UTIs
"The FDA is committed to fostering new antibiotic availability when they prove to be safe and effective, and Pivya will provide an additional treatment option for uncomplicated UTIs," he added.
- What do weight loss drugs mean for a diet industry built on eating less, exercise?
A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He's lost 30 pounds, and has started eating healthier food and exercising — the habits behind ...
- Given their side effects, weight-loss drugs might not be good for all
When will we see through the haze of drugs like Ozempic and Wegovy? Hopefully soon. These drugs might reach 30 million U.S. users by 2030. Surging, off-label demand has come with unintentional ...